Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International Consensus Classification of acute lymphoblastic leukemia/lymphoma
Amy S. Duffield, Charles G. Mullighan, Michael J. Borowitz
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 11-26
Open Access | Times Cited: 79

Showing 26-50 of 79 citing articles:

A comparison of the International Consensus and 5th WHO classifications of T‐cell lymphomas and histiocytic/dendritic cell tumours
Brunangelo Falini, Stefano Lazzi, Stefano Pileri
British Journal of Haematology (2023) Vol. 203, Iss. 3, pp. 369-383
Open Access | Times Cited: 7
Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies
Patrízia Limonta, Raffaella Chiaramonte, Lavinia Casati
Cancers (2024) Vol. 16, Iss. 16, pp. 2861-2861
Open Access | Times Cited: 2
A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia
Jason Xu, Changya Chen, Jonathan H. Sussman, et al.
Nature Cancer (2024)
Open Access | Times Cited: 2
PAX5 fusion genes in acute lymphoblastic leukemia: A literature review
Fatma Mohamed Fouad, Jehane I. Eid
Medicine (2023) Vol. 102, Iss. 20, pp. e33836-e33836
Open Access | Times Cited: 6
Diagnosis and Molecular Pathology of Lymphoblastic Leukemias and Lymphomas in the Era of Genomics and Precision Medicine: Historical Evolution and Current Concepts—Part 2: B-/T-Cell Acute Lymphoblastic Leukemias
Rina Kansal
Lymphatics (2023) Vol. 1, Iss. 2, pp. 118-154
Open Access | Times Cited: 6
The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia
Emanuele Murgo, Elisabetta De Santis, Francesca Sansico, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 6
Progression of follicular lymphoma and related entities: Report from the 2021 SH/EAHP Workshop
Amy S. Duffield, Ahmet Doğan, Catalina Amador, et al.
American Journal of Clinical Pathology (2023) Vol. 159, Iss. 6, pp. 572-597
Open Access | Times Cited: 5
Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype
Ruifang Zheng, Franklin Fuda, Jeffrey Gagan, et al.
Leukemia Research Reports (2023) Vol. 21, pp. 100410-100410
Open Access | Times Cited: 5
Epidemiology of childhood acute leukemias
M. Ciesielska, Beata Orzechowska, Andrzej Gamian, et al.
Postępy Higieny i Medycyny Doświadczalnej (2024) Vol. 78, Iss. 1, pp. 22-36
Open Access | Times Cited: 1
Effects of ferroptosis‐related gene HSPB1 on acute myeloid leukemia
X H Yan, Yujiao Sun, Juan Du, et al.
International Journal of Laboratory Hematology (2024)
Closed Access | Times Cited: 1
The Bloody Crossroads: Interactions between Periodontitis and Hematologic Diseases
Michał Łobacz, Paulina Mertowska, Sebastian Mertowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6115-6115
Open Access | Times Cited: 1
Implementation of pharmacogenetics for treatment of patients with acute lymphoblastic leukemia
Violeta Grajçevci-Uka, Emir Behluli, Rifat Hadžiselimović, et al.
Research Results in Pharmacology (2024) Vol. 10, Iss. 2, pp. 27-39
Open Access | Times Cited: 1
Clinicopathologic Features and Outcomes of Acute Leukemia Harboring PICALM::MLLT10 Fusion
Jeffrey Wang, Weiwei Zhang, Xinjie Xu, et al.
Human Pathology (2024) Vol. 151, pp. 105626-105626
Closed Access | Times Cited: 1
Aptamer sgc8-Modified PAMAM Nanoparticles for Targeted siRNA Delivery to Inhibit BCL11B in T-Cell Acute Lymphoblastic Leukemia
Xiangbo Zeng, Dingrui Nie, Zhen Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 12297-12309
Open Access | Times Cited: 1
Classification of acute lymphoblastic leukemia using improved ANFIS
M. Anline Rejula, S. Amutha, G. M. Shilpa
Multimedia Tools and Applications (2023) Vol. 82, Iss. 23, pp. 35475-35491
Closed Access | Times Cited: 4
Therapeutic applications of CRISPR/Cas9 mediated targeted gene editing in acute lymphoblastic leukemia: current perspectives, future challenges, and clinical implications
Alan Jhones Barbosa de Assis, Brunna Letícia de Oliveira Santana, Ana Cristina Moura Gualberto, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Diagnostic approach to leukemia cutis : A differential diagnostic step-by-step algorithm
Alex Jenei, Alexandar Tzankov
American Journal of Clinical Pathology (2024)
Open Access | Times Cited: 1
Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia
Olga Krali, Yanara Marincevic-Zuniga, Gustav Arvidsson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
ICC‐2022 versus WHO‐2022 classification systems for acute leukemias and myeloid neoplasms: The perspective from two classical morphologists
Gina Zini, John M. Bennett
American Journal of Hematology (2023) Vol. 98, Iss. 8
Open Access | Times Cited: 2
IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1‐like B‐acute lymphoblastic leukaemia
Catherine K. Gestrich, Shanelle J. De Lancy, Adam Kresak, et al.
British Journal of Haematology (2023) Vol. 204, Iss. 1, pp. 229-239
Open Access | Times Cited: 2
Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia
Abdulrhman S. Elbnnani, Mohamed Elbasir, Salah Altabal, et al.
Libyan Journal of Medicine (2024) Vol. 19, Iss. 1
Open Access
The impact of MCCK1, an inhibitor of IKBKE kinase, on acute B lymphocyte leukemia cells
Shuangshuang Wen, Peng Zhao, Siyu Chen, et al.
Mathematical Biosciences & Engineering (2024) Vol. 21, Iss. 4, pp. 5164-5180
Open Access
Clinicopathologic Features and Outcomes of Acute Leukemia Harboring Picalm::Mllt10 Fusion
Jeffrey Wang, Weiwei Zhang, Xinjie Xu, et al.
(2024)
Closed Access
Chidamide maintenance therapy after allo-HSCT in SET-NUP214 fusion positive T-ALL patients: A report of two cases
Jingyu Song, Jie Liu, Dan Guo, et al.
Transplant Immunology (2024) Vol. 87, pp. 102119-102119
Closed Access
Philadelphia chromosome-positive or Philadelphia chromosome-like B-cell precursor acute lymphoblastic leukemia with multilineage involvement in pediatric patients: a report of two cases and literature review
Han Lin, Lu Chen, Ruoyao Huang, et al.
Pharmacogenetics and Genomics (2024)
Open Access

Scroll to top